Ran Zhu, Ph.D.
Institution:
University of Virginia, Charlottesville, VAArea:
Bioorganic and Synthetic Organic ChemistryGoogle:
"Ran Zhu"Mean distance: 8.25
Parents
Sign in to add mentorTimothy L. Macdonald | grad student | 2008 | UVA | |
(Synthesis and biological evaluation of conformationally constrained sphingosine -1 -phosphate analogs as subtype selective S1P receptor agonist/antagonist.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kennedy PC, Zhu R, Huang T, et al. (2011) Characterization of a sphingosine 1-phosphate receptor antagonist prodrug. The Journal of Pharmacology and Experimental Therapeutics. 338: 879-89 |
Sun Q, Zhu R, Foss FW, et al. (2008) In vitro metabolism of a model cyclopropylamine to reactive intermediate: Insights into trovafloxacin-induced hepatotoxicity Chemical Research in Toxicology. 21: 711-719 |
Zhu R, Snyder AH, Kharel Y, et al. (2007) Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist. Journal of Medicinal Chemistry. 50: 6428-35 |
Sun Q, Zhu R, Foss FW, et al. (2007) Mechanisms of trovafloxacin hepatotoxicity: Studies of a model cyclopropylamine-containing system Bioorganic and Medicinal Chemistry Letters. 17: 6682-6686 |
Zhu R, Frazier CR, Linden J, et al. (2006) N6-ethyl-2-alkynyl NECAs, selective human A3 adenosine receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16: 2416-8 |
Kharel Y, Lee S, Snyder AH, et al. (2005) Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. The Journal of Biological Chemistry. 280: 36865-72 |